JNJ-39823277

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-39823277, covering 2014-01-30 to 2014-01-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate of the Absorption, Metabolism, and Excretion of 14C-JNJ-39823277 in Healthy Male Participants [Phase 1]

See pricing